|
Apr 14
|
Top Premarket Gainers
|
|
Apr 14
|
Third Harmonic outlines plans for dissolution
|
|
Apr 14
|
Third Harmonic Seeks to Liquidate, Dissolve Company
|
|
Apr 14
|
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
|
|
Feb 14
|
Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Feb 14
|
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)
|
|
Feb 12
|
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
|
|
Feb 11
|
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
|
|
Feb 11
|
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK
|
|
May 28
|
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
|
|
May 15
|
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
|
|
May 14
|
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
|
|
May 10
|
Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD)
|
|
Apr 15
|
Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
|
|
Apr 8
|
We're Not Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn
|
|
Mar 28
|
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
|
|
Mar 27
|
Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns with Analyst Projections
|
|
Mar 26
|
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
|
|
Dec 8
|
Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares
|